Anthem Biosciences, a Bengaluru-based contract research, development, and manufacturing organization (CRDMO), opened its initial public offering (IPO) on Monday, July 14. The issue, which closes on July 16, is entirely an offer for sale (OFS) of Rs 3,395 crore, with no fresh issue component. The company will be listed on both the NSE and BSE.